Scythian Biosciences Corp. Forms Professional Athlete Advisory Committee
September 27, 2017 17:00 ET
|
Scythian Biosciences Corp.
TORONTO, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company") (TSX-V:SCYB) is pleased to announce the formation of its Professional Athlete Advisory Committee. The purpose...
Scythian Biosciences Corp. Appoints Chief Scientific Officer
September 05, 2017 06:00 ET
|
Scythian Biosciences Corp.
TORONTO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company") (TSX-V:SCYB) is pleased to announce that Maghsoud Dariani has become the Chief Scientific Officer of the...
Scythian Biosciences Corp. Applies for Listing of Common Stock on NASDAQ
August 29, 2017 17:59 ET
|
Scythian Biosciences Corp.
TORONTO, Aug. 29, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (TSXV:SCYB) (the "Company") is pleased to announce that it has submitted an initial listing application to list its common...
Scythian Biosciences Corp. Retains The Weinberg Group To Provide FDA Consulting Services
August 28, 2017 11:22 ET
|
Scythian Biosciences Corp.
TORONTO, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company”) (TSXV:SCYB) is pleased to announce that it has entered into a consulting arrangement with The Weinberg Group and...
Scythian Biosciences Corp. Retains Hybrid Financial Ltd. for Investor Relations Activities
August 17, 2017 09:24 ET
|
Scythian Biosciences Corp.
TORONTO, Aug. 17, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “Company”) (TSXV:SCYB) announces that it has retained the services of Hybrid Financial Ltd. (”Hybrid Financial”) for...